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Background: Traumatic brain injury (TBI) enhances pro-inflammatory responses, neuronal loss and long-term
behavioral deficits. Caveolins (Cavs) are regulators of neuronal and glial survival signaling. Previously we showed
that astrocyte and microglial activation is increased in Cav-1 knock-out (KO) mice and that Cav-1 and Cav-3
modulate microglial morphology. We hypothesized that Cavs may regulate cytokine production after TBI.
Methods: Controlled cortical impact (CCI) model of TBI (3 m/second; 1.0 mm depth; parietal cortex) was performed
on wild-type (WT; C57Bl/6), Cav-1 KO, and Cav-3 KO mice. Histology and immunofluorescence microscopy (lesion
volume, glia activation), behavioral tests (open field, balance beam, wire grip, T-maze), electrophysiology, electron
paramagnetic resonance, membrane fractionation, and multiplex assays were performed. Data were analyzed by
unpaired t tests or analysis of variance (ANOVA) with post-hoc Bonferroni’s multiple comparison.
Results: CCI increased cortical and hippocampal injury and decreased expression of MLR-localized synaptic proteins
(24 hours), enhanced NADPH oxidase (Nox) activity (24 hours and 1 week), enhanced polysynaptic responses (1
week), and caused hippocampal-dependent learning deficits (3 months). CCI increased brain lesion volume in both
Cav-3 and Cav-1 KO mice after 24 hours (P < 0.0001, n = 4; one-way ANOVA). Multiplex array revealed a significant
increase in expression of IL-1β, IL-9, IL-10, KC (keratinocyte chemoattractant), and monocyte chemoattractant protein
1 (MCP-1) in ipsilateral hemisphere and IL-9, IL-10, IL-17, and macrophage inflammatory protein 1 alpha (MIP-1α) in
contralateral hemisphere of WT mice after 4 hours. CCI increased IL-2, IL-6, KC and MCP-1 in ipsilateral and IL-6,
IL-9, IL-17 and KC in contralateral hemispheres in Cav-1 KO and increased all 10 cytokines/chemokines in both
hemispheres except for IL-17 (ipsilateral) and MIP-1α (contralateral) in Cav-3 KO (versus WT CCI). Cav-3 KO CCI
showed increased IL-1β, IL-9, KC, MCP-1, MIP-1α, and granulocyte-macrophage colony-stimulating factor in ipsilateral
and IL-1β, IL-2, IL-9, IL-10, and IL-17 in contralateral hemispheres (P = 0.0005, n = 6; two-way ANOVA) compared to
Cav-1 KO CCI.
Conclusion: CCI caused astrocyte and microglial activation and hippocampal neuronal injury. Cav-1 and Cav-3 KO
exhibited enhanced lesion volume and cytokine/chemokine production after CCI. These findings suggest that Cav
isoforms may regulate neuroinflammatory responses and neuroprotection following TBI.* Correspondence: bhead@ucsd.edu
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Traumatic brain injury (TBI) is the leading cause of mor-
bidity and mortality among young people in the Western
world. Patients with TBI sustain long-term neurological,
cognitive and behavioral deficits leading to a greater
requirement for institutional and long-term care. Des-
pite intensive investigative efforts, there is a paucity of in-
terventions designed to reduce morbidity and mortality
associated with TBI [1].
Immediately following TBI, there is a substantial ex-
cess release of neurotransmitters such as glutamate and
signaling nucleotides such as adenosine. Excessive glu-
tamate leads to hyperactivation of N-methyl-D-aspartate
receptor (NMDAR) and subsequent excitotoxic neuronal
injury. Recent data indicate that hyperactivation of glu-
tamate receptors is short lived (< 1 hour), and there is
a substantial reduction in NMDAR expression and
signaling within 48 hours of injury [2,3]. Signaling
pathways and molecules that are normally associated
with neuronal survival (such as BDNF, TrkR, Src, ERK,
cAMP and CREB) are reduced for several weeks fol-
lowing TBI [2,4,5]. In addition to glutamate release and
neuronal loss, TBI can also produce astro- and microglio-
sis and enhance the production of proinflammatory cyto-
kines [6-9]. This increased cytokine production can
result in alterations in synaptic connections that can lead
to additional neuronal loss. The latter effect can con-
tribute to post-traumatic epilepsy (PTE) and long-
term behavioral dysfunction with few therapies readily
available [10-13].
Membrane/lipid rafts (MLRs) are discrete regions of the
plasma membrane enriched in cholesterol, glycosphingoli-
pids and sphingomyelin, and the cholesterol binding and
scaffolding protein caveolin (Cav). Three isoforms exist,
with Cav-1 and Cav-2 usually co-expressed in a wide var-
iety of tissues, while Cav-3 is canonically expressed in stri-
ated muscle [14]. All three isoforms have been described
in the central nervous system (CNS) [15-17]. Cav-1 partic-
ipates in the inflammatory response to the endotoxin lipo-
polysaccharide through toll-like receptor 4 (TLR4) and
through negative regulation of endothelial nitric oxide
synthase (eNOS) [18]. Cav-3, normally associated with
striated muscles, is not well studied in the CNS. We
have recently shown that astrogliosis and microgliosis
is increased in the brains of young Cav-1 knock-out
(KO) mice [19], and that Cav-1 and Cav-3 modulate
microglia morphology [20]. It is therefore conceivable
that Cav-1 and Cav-3 might play an important role in
the neuroinflammatory response in the brain following
controlled cortical impact (CCI). To address this hypoth-
esis, we first performed a variety of assays on wild-type
(WT) mice with and without CCI (that is, histological,
biochemical, electrophysiological, and by electron para-
magnetic resonance (EPR)) to demonstrate establishmentof the TBI model. We next conducted CCI and measured
the neuroinflammatory response in the brains of WT,
Cav-1 KO and Cav-3 KO mice subjected to CCI.
Materials and methods
Animal care
All animals were treated in compliance with the Guide
for the Care and Use of Laboratory Animals (National
Academy of Science, Washington, DC, USA). All animal-
use protocols were approved by the Veterans Administration
San Diego Healthcare System Institutional Animal Care
and Use Committee (IACUC, San Diego, California, USA)
prior to performed procedures. C57BL/6 WT and Cav-1
KO mice were purchased from Jackson Laboratories (Bar
Harbor, ME, USA) and Cav-3 KO mice were a kind gift
from Drs Ishikawa (Professor, Cardiovascular Research
Institute, Yokohama City University School of Medicine,
Yokohama, Japan) and Hagiwara (Professor, National
Institute of Neuroscience, Kodaira, Tokyo, Japan) [21].
Reagents
The following primary antibodies were used for Western
blot (WB) and immunofluorescence microscopy (IF) ana-
lysis: Abcam (1 Kendall Square, Suite B2304, Cambridge,
MA 02139-1517, USA) - A2AAR #ab79714, β3-tubulin
#ab11314, Cav-3 #ab2912, MAP2 #ab32454; BD Trans-
duction Labs (2350 Qume Drive, San Jose, CA 95131,
USA) - NR2B #610417, TrkB #610102; Cell Signaling
(3 Trask Lane, Danvers, MA, 01923, USA) - AMPAR
#2460 s, Cav-1 #3267, NR1 #4204, NR2A #4205, PSD-95
#2507; Epitomics (863 Mitten Road, Suite 103, Burlingame,
CA, 94010-1303, USA) - LDLR #1956-1, LRP-1 #2703-1;
Imgenex (11175 Flintkote Ave, Suite E, San Diego, CA,
92121, USA) - GAPDH #IMG-5019A-1; Millipore (290
Concord Road, Billerica, MA, 01821, USA) - GFAP
AB5541; Santa Cruz (10410 Finnell Street, Dallas, TX,
75220, USA) - A1AR sc-28995, A3AR sc-12938, TLR4 sc-
30002, goat anti-mouse IgG-HRP sc-2031, goat anti-rabbit
IgG-HRP, sc-2030 goat anti-rat IgG-HRP sc-2006;
Stressgen (4243 Glanford Avenue, Victoria, BC, Canada) -
HSP90 #SPA835; WAKO (1-2 Doshomachi 3-Chome,
Chuo-Ku, Osaka, 540-8605, Japan) - Iba1 WB #016-
20001, IF #019-19741; Molecular Probes (3175 Staley
Road, Grand Island, NY, 14072, USA) - goat anti-rabbit-
488 IgG (H + L) #A11008, goat anti-mouse-594 IgG
(H + L) #A11005.
Controlled cortical impact model of traumatic brain injury
CCI was performed as described previously [22]. Briefly,
isoflurane (2% vol/vol) anesthetized mice were fixed
into a stereotactic frame, maintaining basal temperature
(37°C) throughout the procedure. A burr hole was made
approximately 5 mm anterior to posterior (0 to −5 A-P)
from the bregmatic suture and 4 mm laterally from the
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were made with a portable drill over the right parietotem-
poral cortex and the bone flap was removed. Using a
stereotaxic impactor (Impact One™; myNeuoLab.com), a
3-mm tip was accelerated down to a 1 mm depth at a
speed of 3 m/second with an 85 ms dwell time.
Histology (n = 4/group) and immunofluorescence
(n = 3/group)
For histology, animals were transcardially perfused with
4% paraformaldehyde in 0.1 M PO4 buffer then stored in
the same buffer for 24 hours and processed for paraffin
embedding. Serial sections through the hippocampus
(two 5-μm sections per slide, 100 μm apart) were stained
with Masson’s trichrome. Digital virtual slides obtained
with Aperio Scanscope CS-1 scanner were used for ex-
tensive computer assisted morphometry in a Spectrum
image analysis system (Aperio Technology Inc., 1700
Leider Lane, Buffalo Grove, IL, 60089, USA). Scanscope
software and associated algorithms were applied for
measurements of lesion volume and the count of dead
or viable neurons in the impact zone, penumbra and
relevant area of the contralateral hemisphere control
(internal control) as described by Krajewska and col-
leagues [23]. Whole brains were perfused with 4% parafor-
maldehyde, cryoprotected with 30% sucrose and frozen
for cryostat sectioning in optimal cutting temperature
embedding media. Free floating sections (50 μm) were
washed in phosphate-buffered saline, blocked and in-
cubated overnight with primary antibodies followed
by species-specific secondary antibodies. Species-specific
fluroconjugated Alexa® (3175 Staley Road, Grand Island,
NY, 14072, USA) secondary antibodies were used at a
1:500 dilution with DAPI in 10% goat blocking solu-
tion. Sections were incubated for 1 to 2 hours at room
temperature, gently rotating. We have previously charac-
terized and optimized our immunofluorescence protocols
for GFAP (glial fibrillary acidic protein), Iba1 (ionized
calcium-binding adapter molecule 1) and MAP2 (micro-
tubule associated protein 2) as previously described
[19,20,24,25]. Incubation with 10% goat and no primary
antibodies, with and without secondary antibodies, served
as controls samples for these experiments. Coverslips or
brain sections were mounted with an anti-fade solution
and imaged; when appropriate, matched exposures were
obtained. All other images were exposure and saturation
optimized. All quantitation was done using NIH Image J.
Cognitive and motor tests (n = 20/group)
Male mice (2 to 3 months old) were subjected to CCI
and monitored for an additional 3 months followed by a
behavioral battery. Open field activity allows assessment
of basic activity and general behavior/anxiety of the
mouse. Locomotion was recorded and analyzed by acomputerized video tracking system (Noldus XT 7.1, 1503
Edwards Ferry Road, Suite 310, Leesburg, VA, 201276,
USA). Animals were habituated to the testing room; spon-
taneous locomotion was assessed in a white plexiglass
open field box (41 × 41 × 34 cm enclosures) for 10 minutes.
Recorded parameters were distance moved (cm), velocity
(cm/second), and time spent in the center of the arena
represented by 50% of the total arena (seconds). The wire
grip test tests the ability of mice to hang on a metal rail
[26]. The metal wire is situated 40 cm from the ground
and a soft surface is placed below the wire to prevent
physical trauma to the mice. Latency to fall was timed and
the test was repeated three times with an inter-trial inter-
val of 30 seconds. The highest latency to fall was multi-
plied with the body weight to present the holding impulse
(seconds × g). In the beam-walking test, mice traverse an
elevated narrow beam to reach a platform. The protocol
described here measures foot slips while crossing the
beam. The apparatus was custom made according to a
published protocol of Carter and colleagues [27] with the
height of the apparatus set at 50 cm. Continuous alternat-
ing T-maze test was used to assess the cognitive ability of
the CCI mice; this enclosed apparatus is in the form of a T
placed horizontally. Animals are started from the base of
the T and allowed to choose one of the goal arms abutting
the other end of the stem. Two trials are given in quick
succession; on the second trial the rodent tends to choose
the arm not visited before, reflecting memory of the first
choice, termed as ‘spontaneous alternation’. We assessed
this tendency in a test with 14 possible alternations ac-
cording to plans and a protocol from a previously pub-
lished method [28,29].
Electrophysiology (n = 4/group)
Transverse hippocampal slices were prepared as previ-
ously described [30]. Mice were anesthetized with isoflur-
ane before decapitation. The brain was quickly removed
and immersed for 2 minutes in ice-cold artificial cerebro-
spinal fluid (ACSF) containing 119 mM NaCl, 2.5 mM
KCl, 2.5 mM CaCl2, 1.3 mM MgSO4, 1 mM NaH2PO4,
26 mM NaHCO3, 10 mM glucose, osmolarity 310 mOsm,
continuously bubbled with carbogen (95% O2-5% CO2),
pH 7.4. The hippocampus was extracted and cut in ice
cold ACSF with a vibratome (Leica 1000, 1700 Leider
Lane, Buffalo Grove, IL, 60089, USA) into 350 μm slices,
which were allowed to recover in oxygenated ACSF at
35°C for 30 minutes, and then at room temperature for at
least 1 hour prior to experimental recordings.
A slice was transferred into the submerged recording
chamber and superfused with ACSF at a constant rate of
1.0 ml/minute at 32°C. To prevent de-oxygenation of
ACSF in the recording chamber, the surface was con-
tinuously blown over by carbogen warmed to 32°C. Record-
ing electrodes were made of borosilicate glass capillaries
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and filled with ACSF (resistance 0.3 to 0.5 MΩ). Monopo-
lar stimulating electrodes were made of Pt/Ir wires of diam-
eter 25.4 μm (PTT0110, World Precision Instruments) and
had 100 μm long exposed tips. The stimulating and re-
cording electrodes were inserted under visual control per-
pendicular to the slice surface into the CA1 stratum
radiatum 80 to 100 μm from the pyramidal layer, at a dis-
tance of 300 to 350 μm apart from each other. The magni-
tude of monosynaptic responses was evaluated as initial
slope of field excitatory postsynaptic potential at latencies
0.1 to 0.9 ms, and the magnitude of polysynaptic re-
sponses as the averaged amplitude at latencies 12 to
45 ms after the stimulus. Testing stimuli (duration 100 μs,
currents 60 to 80 μA) evoked field responses with ampli-
tudes of 70 to 80% of maximum. Long-term potentiation
was induced by tetanizations consisting of a single train of
stimuli: 1 second at 100 Hz.Superoxide measurements in synaptosomes by electron
paramagnetic resonance (n = 3/group)
Brain NADPH oxidase (Nox) activity was assayed by de-
tecting superoxide radical in synaptosomal isolations using
EPR spin trapping spectroscopy according to a previously
published protocol [31]. Synaptosomal protein (0.2 to
0.5 mg) was mixed with 70 mM 5-(diethylphosphoryl)-5-
methyl-1-pyrroline-N-oxide (Axxora, San Diego, CA, USA)
and combinations of the substrates/inhibitors was loaded
into a 50 μl glass capillary and introduced into the EPR
cavity of a MiniScope MS300 Benchtop spectrometer
(Louis-Bleriot-Str. 5, D-12487, Berlin, Germany) at a con-
stant temperature of 37°C. Time evolution of the EPR
spectra was recorded over 11 minutes from triggering
Nox activity by adding appropriate combinations of sub-
strates. For correlative analysis, the signals were quanti-
fied over the acquisition time of approximately 6 minutes
(that is, the area under oxidative burst curves and nor-
malized by the protein concentration). EPR conditions
were as follows: microwave power, 5 mW; modulation
amplitude, 2 G; modulation frequency, 100 kHz; MW
frequency, 9.49 kHz; sweep width, 150 G centered at
3349.0 G; scan rate, 7.5 G/s and each spectrum was
the average of 2 scans.Cell culture
Primary cells were isolated using a Papain dissociation
kit (#3150; Worthington Chemicals, Lakewood, NJ,
USA) as previously described [20,24,25]. Cultures were
obtained from post-natal day 3 mouse pups. Mixed glia
were separated from neurons according to manufac-
turer’s instructions and grown to confluence in T-75
flasks in Dulbecco’s modified Eagle’s medium with 10%
fetal bovine serum.Sucrose density fractionation and Western blot
(n = 4/group)
Mouse cortex (50 to 100 mg) was homogenized using a
carbonate lysis buffer (500 mM sodium carbonate,
pH 11.0) containing protease and phosphatase inhibi-
tors. Lysates were sonicated (three cycles for 15 seconds
on ice). Protein was quantified by Bradford assay and
normalized to 1 mg/ml. Sucrose was dissolved in MES
buffered saline (25 mM MES (2-(N-morpholino)ethane-
sulfonic acid) and 150 mM NaCl, pH 6.5) buffer to pre-
pare 80%, 35% and 5% solutions [25]. Sucrose gradients
were prepared by adding 1 ml 80% sucrose followed by
1 ml sonicated sample with brief vortexing followed by
6 ml 35% sucrose followed by 4 ml 5% sucrose. Gradi-
ents were spun in an ultracentrifuge using an SW-41
rotor at 39 krpm at 4°C for 3 hours. Fractions (1 ml)
were collected from the top of each tube starting at 4 ml
to 12 ml. CCI samples were run as individual fractions
and f4-6 (buoyant fractions; BF) and f10-12 (heavy frac-
tions; HF) combined for WB. Samples were run on 10%
or 4 to 12% bis-tris gels. After transfer to polyvinylidene
fluoride membranes, samples were incubated with block-
ing buffer (3% bovine serum albumin in 20 mM Tris
buffered saline containing 1% Tween) for 30 minutes
and then incubated overnight with primary antibodies
(in blocking buffer) at 4°C. Next day, membranes were
washed (3 × 15 minute washes) and re-incubated with
species-specific secondary antibodies conjugated to horse-
radish peroxidase from Santa Cruz at 1:5000 dilution in
blocking buffer for 1 hour at room temperature. After ex-
tensive washing (4 to 5 × 15 minute washes) membranes
were incubated with enhanced chemiluminescence re-
agent (Amersham Biosciences, PO Box 117, Rockford, IL,
61105, USA) and imaged with the UVP BioSpectrum
Imaging System (UVP, 2066 W. 11th Street, Upland, CA,
91786 and saved as .tif files. Densitometric analysis was
measured as previously described [25].
MAGPIX cytokine multiplex assay (n = 6/group)
CCI or sham was performed on the WT, Cav-1 KO and
Cav-3 KO mice (2 to 3 months old) and cytokine multi-
plex assay was performed on the cortex 4 hours post-CCI.
Cortices were harvested and frozen 4 hours post-CCI sep-
arately from each hemisphere in liquid nitrogen. Frozen
tissue was homogenized following the manufacturer’s in-
structions and 25 μl undiluted homogenate was added to
25 μl assay buffer. Magnetic beads (bead size = 6.45 μm)
coated with specific antibodies (RCYTOMAG-80 K-PMX)
were added to this solution and the reaction was incu-
bated at 4°C for 24 hours. The beads were washed and in-
cubated with 24 μl biotinylated detection antibody at
room temperature for 2 hours. Completing the reaction,
25 μl streptavidin–phycoerythrin conjugate compound
was added and allowed to incubate for 30 minutes at
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150 μl sheath fluid for 5 minutes. Concentration of the
samples was determined by Bio-Plex Manager version 5.0,
after fluorescent capture, and MAGPIX xPONENT soft-
ware (Millipore, 290 Concord Road, Billerica, MA, 01821,
USA [32]. The assays were run in triplicate to confirm
the results. Samples were normalized to total protein
concentration. Samples were analyzed for the following:
IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13,
IL-17, IL-18, IFNγ, induced protein 10, chemokine C-C
motif ligand (CCL)2 (previously known as monocyte
chemoattractant protein 1; MCP-1), CCL3 (previously
known as macrophage inflammatory protein 1 alpha;
MIP-1α), CCL5 (also known as Regulated upon Activation
Normal T-cell Expressed; RANTES), TNFα, vascular
endothelial growth factor, eotaxin, growth related onco-
gene KC (keratinocyte chemoattractant) (CXCL1), leptin,
granulocyte colony-stimulating factor, and granulocyte-
macrophage colony-stimulating factor (GMCSF).
Statistical analysis
All data were analyzed by unpaired t tests or analysis of
variance (ANOVA) with post-hoc Bonferroni’s multiple
comparison or Student Neuman Keuls test as appropriate.
Significance was set at P < 0.05. All data are presented as
mean ± SEM. All statistical analysis was performed using
Prism 6 (GraphPad Software, Inc., 7825 Fay Avenue, Suite
230, La Jolla, CA, 92037.
Results
Verification of a controlled cortical impact model of
traumatic brain injury shows neuronal damage after
24 hours
To assess cortical and hippocampal damage after CCI,
serial coronal sections of the brain were prepared and
stained with Masson’s trichrome. Figure 1A (2 hours post-
CCI) and Figure 1C (24 hours post-CCI) are coronal sec-
tions showing cortical lesions. The inserts (boxed areas)
are representative of the underlying hippocampal re-
gions (a and b). Neuronal injury was analyzed for dying
neurons by Aperio ScanScope imaging and Spectrum
analysis algorithm packages as described by Krajewska
and colleagues [22], with dead neurons indicated by
red/brown coloring superimposed. The results showed
minimal hippocampal cell death at 2 hours post-CCI
(n = 4) in either ipsilateral or contralateral hemispheres
but considerable cell death in CA1 and CA3 is evident
at 24 hours post-CCI (n = 4) (Figure 1C-a). Sucrose
density fractionation revealed that MLR localization
of synaptic proteins and receptors (PSD-95, TrkB,
NR2B) and Cav-1 was still intact 2 hours post-CCI
(Figure 1B), but there was a drastic reduction after
24 hours (Figure 1D). These results show that there
is CA1 neuronal cell death 24 hours post-CCI and aloss in MLR-localized pro-survival and pro-growth synap-
tic components.
Hippocampal-dependent learning is decreased 3 months
post-controlled cortical impact
Behavioral analysis revealed no significant difference be-
tween CCI (n = 20) and sham (n = 20) for open field dis-
tance (cm) moved (CCI versus sham: 6,413 ± 217 versus
6,479 ± 216; P = 0.793), velocity (cm/second) (CCI versus
sham: 12.88 ± 0.49 versus 13.56 ± 0.34; P = 0.41) or time
spent in the center of the arena (seconds) (CCI versus
sham: 46.9 ± 6.8 versus 41.12 ± 3.25; P = 0.61) (Figure 1E).
Furthermore no significant difference was seen in foot
slips on the balance beam (CCI versus sham: 1.5 ± 0.2
versus 1.4 ± 0.3; P = 0.56) or the holding impulse (sec-
onds x grams) in the wire grip test (CCI versus sham:
1,606 ± 146 versus 1,450 ± 110; P = 0.4). However, a sig-
nificant difference between groups was recorded in the
alternations made (% alternations) in the continuous al-
ternating T-maze (CCI versus sham: 59.6 ± 3.7 versus
71.8 ± 3.0; P = 0.028) (Figure 1F). Taken together, the re-
sults suggest that no gross difference between groups
was present in read outs of basic activity, general behav-
ior/anxiety and neuromuscular function, yet there was a
difference in hippocampal dependent ‘spontaneous alter-
nations’, suggesting that the hippocampal injury detected
histologically in Figure 1C and the subcellular biochem-
ical changes seen in Figure 1D may contribute to the
hippocampal-dependent behavioral changes.
Controlled cortical impact model of traumatic brain injury
enhances polysynaptic responses in isolated hippocampal
slices at 1 week
Electrophysiological changes were assessed in hippocam-
pal slices isolated from contralateral (n = 4) and ipsilateral
(n = 4) hemispheres. No changes in long-term potentiation
of monosynaptic responses were observed (Figure 2A,B).
However, changes in the response shape were more pro-
nounced in the ipsilateral (CCI) versus the contralateral
slices. Thus, the averaged amplitude of the field poten-
tials at 14 to 45 ms that represent mostly polysynaptic re-
sponses were considerably greater in the ipsilateral versus
contralateral slices from CCI brains (Figure 2A,C). The
observed increase in polysynaptic responses in the CCI
hippocampal hemisphere is an indicator of increased pro-
epileptic activity, and this neurophysiological change
could be an important component that contributed to the
behavioral change observed in Figure 1F.
Controlled cortical impact model of traumatic brain injury
exhibits enhanced NADPH oxidase activity
To test if injury-induced neuronal loss and the subse-
quent neuroinflammation in our current TBI model are
associated with Nox activation, Nox activity was assessed
Figure 1 Controlled cortical impact (CCI) is a viable model of murine traumatic brain injury (TBI). (A) Trichrome stained paraffin section
2 hours post-CCI with both ipsilateral and contralateral hemispheres. Bottom panels (a) and (b) are the enlargements of the hippocampal area
outlined. (B) Sucrose density fractionation (SDF) to purify membrane/lipid rafts (MLRs) from ispilateral and contralateral hemispheres. Buoyant
fractions contain the cholesterol and sphingolipid enriched MLR, while heavy fractions contain non-MLR cellular components. Western blot of
SDF purification of MLR from ipsilateral and contralateral hemispheres 2 hours post-CCI. (C) Trichrome stained paraffin section 24 hours post-CCI
shows considerable damage to ipsilateral cortex and underlying hippocampus. Bottom panels (a) and (b) are the enlargements of the hippocampal
area outlined. (D) Western blot of SDF purification of MLR from ipsilateral and contralateral hemispheres 24 hours post-CCI. (E) Behavior battery tests
performed 3 months post-CCI: open field (distance, velocity, time spent), footslips and wire grip. (F) T-maze alternation behavioral test on sham and
CCI groups after 3 months.
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(Figure 2D,E). TBI mice exhibited enhanced Nox-
derived superoxide generation 24 hours and 1 week after
CCI in both contralateral and ipsilateral hemispheres.
Interestingly, increased Nox activity in the contralateral
side indicates that ‘global’ brain inflammation was induced
1 week post-CCI.
Caveolin knock-out animals have altered expression of
membrane/lipid raft localized neuronal and glial proteins
WT, Cav-1 KO and Cav-3 KO mouse cortex were homog-
enized and processed for sucrose density fractionation toanalyze neuronal and glial proteins (Figure 3). BF (consist-
ing of fractions 4 to 6) and HF (consisting of fractions 10
to 12) were used for WB. PSD-95, NR2A, NR2B, and
TrkB were all reduced in both BF and HF from Cav-1 KO
brains, results akin to our previously published work [19].
BF from Cav-3 KO brains showed increased expression of
PSD-95, NR2B, NR1A, and TrkB (Figure 3A) compared to
Cav-1 KO, yet the pattern-recognition receptor TLR4 was
nearly lost in HF from Cav-3 KO brains and decreased in
Cav-1 KO (Figure 3B).
Adenosine receptors exhibited differential expression
patterns among the three groups (Figure 3B). WT brains
Figure 2 Electrophysiological properties of the commissural-collateral input in the CA1 region of the hippocampus at 1 week
post-traumatic brain injury (TBI). (A) Representative responses in slices from the contralateral (Contra; left) and the TBI (controlled
cortical impact (CCI), right) hippocampus before and after the tetanus. (B) Long-term potentiation (LTP) of monosynaptic responses after
CCI. (C) Changes of polysynaptic response (averaged amplitude at latencies 12 to 45 ms after the stimulus). (D) Enhanced NADPH oxidase
(Nox) activity in both ipsilateral and contralateral hemispheres 24 hours and 1 week post-TBI as shown by increased superoxide electron
paramagnetic resonance (EPR) signal amplitude relative to sham animals. (E) Isolated synaptosomes from the ipsilateral side exhibited
greater Nox activity, which increased 1 week post-CCI. Con, control; Contra, contralateral; fEPSP, field excitatory postsynaptic potential;
Ispi, ipsilateral.
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promoting subtype of adenosine receptors. Interestingly,
A2AR expression was enhanced in both Cav KO brains,
with Cav-3 KO displaying the highest BF-localized ex-
pression. The anti-inflammatory A1AR and A3AR iso-
forms were only detected in HF for all groups. Cav-1
and Cav-3 KO mice expressed less A1AR and A3AR
compared to WT.
Because Cavs are cholesterol binding proteins, and
lipoprotein receptors LRP-1 and LDL-R subcellularly
localize to MLR [33,34], we assessed the expression of
these receptors (Figure 3C). Both Cav-1 KO and Cav-3
KO showed decreased expression of LRP-1, with the
same ratio of BF to HF. There was little detection of
LDL-R in BF from WT, Cav-1 and Cav-3 KO, yet Cav-3
KO showed the least expression compared to Cav-1 KO
and WT. The KO phenotype was confirmed by WB for
Cav-1 KO and Cav-3 KO hippocampi.Caveolin knock-out animals have altered resident central
nervous system cell populations
Primary mixed glial cultures were isolated from WT,
Cav-1 KO and Cav-3 KO on postnatal day 3 to match
passage and days in vitro. WB analysis (Figure 4A) and
IF (immunofluorescence microscopy) (Figure 4B) indi-
cate that Cav-1 KO and Cav-3 KO have increased num-
ber of Iba1 positive cells and decreased GFAP positive
cells compared to WT, with Cav-3 KO cells showing the
greatest reduction in GFAP positive cells as indicated by
IF (Figure 4B, right image). To confirm these findings,
age-matched hippocampi were examined by IF for Iba1
(microglia), GFAP (astrocytes) (Figure 4C) and MAP2
(neuronal dendrites) (Figure 4D). Cav-1 KO brains ex-
hibit slightly increased Iba1 positive microglia and GFAP
positive staining in CA1 and dentate gyrus (DG) com-
pared to WT, similar to previously reported findings
from our group [19]. Hippocampi from Cav-3 KO brains
Figure 3 Caveolin (Cav)-1 knock-out (KO) and Cav-3 KO mice
have altered expression and membrane/lipid raft (MLR)
localization of key neuronal and glial proteins. Sucrose density
fractionation (SDF) and Western blot (WB) of wild-type (WT), Cav-1
KO, and Cav-3 KO brains. Buoyant fractions (BF) contain the cholesterol
and sphingolipid enriched MLR, while heavy farctions (HF) contain
non-MLR cellular components. (A) WB detection of PSD-95, NR2B,
NR1 and TrkB expression in BF and HF. (B) WB detection of toll-like
receptor-4 (TLR4), AA2AR, A3AR, and A1AR expression in BF and HF.
(C) WB detection of LRP-1 and LDL-R expression in BF and HF. Bottom
left, WB analysis of GAPDH in whole cell lysates (WCL) from which
SDF were generated for each group. Bottom right, WB shows loss
of Cav-1 and Cav-3 protein expression in the transgenic mouse
used in the present study.
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compared to both WT and Cav-1 KO. WT MAP2 label-
ing of CA1 pyramidal neurons shows a typical pattern of
normally arranged neuronal cell layer and aligned pro-
cesses in the molecular layer of the DG. Cav-1 KO
showed less MAP2 positive neurites, which is consistent
with our previous findings [19], yet Cav-3 KO exhibited
greater MAP2 staining compared to Cav-1 KO and WT
(Figure 4D). Quantitation of the IF images are shown in
Figure 4E: Cav-3 KO showed increased Iba1 positive
cells (P < 0.01, n = 3) compared to WT or Cav-1, less GFAP
positive cells (P < 0.01, n = 3) compared to WT and Cav-1
KO, and increased MAP2 positive neurites (P < 0.01, n = 3)
compared to WT and Cav-1 KO. Basal hippocampi fromWT, Cav-1 and Cav-3 KO were analyzed by WB for Iba1,
GFAP and neuronal specific β3-tubulin to assess the cell-
specific protein expression pattern (Figure 4F). Iba1
was significantly reduced (P < 0.001) in Cav-1 KO and
significantly elevated in Cav-3 KO (P = 0.04). GFAP
was significantly reduced (P = 0.01) and β3-tubulin was el-
evated (P = 0.004) in Cav-3 KO, findings consistent with
IF data.
Caveolin-1 knock-out and Caveolin-3 knock-out mice
exhibit larger lesion volume 24 hours post-controlled
cortical impact compared to wild-type mice
To assess brain injury after CCI, serial coronal sections
of the brain were prepared and stained with Masson’s
trichrome and lesion volume was quantitated as previ-
ously described [22]. Both Cav-1 (n = 4; 11.9 ± 1.2 mm3)
and Cav-3 KO (n = 4; 15.1 ± 2.2 mm3) had a significantly
larger lesion volume compared WT (n = 4; 7.5 ± 0.8 mm3)
and sham (n = 4; 0.8 ± 0.4 mm3) (P < 0.0001, Figure 5)
24 hours post-CCI.
Controlled cortical impact enhances pro-inflammatory
cytokines and chemokines in caveolin-1 knock-out and
caveolin-3 knock-out mice at 4 hours post-impact
Brain homogenates from WT, Cav-1 KO and Cav-3 KO
mice were analyzed for 23 different cytokine/chemokines
to assess the inflammatory response in our CCI model.
Of the 23 analytes, 10 exhibited significantly different
expression patterns among the three groups (Table 1).
Sham data from all three groups (WT, Cav-1 KO and
Cav-3 KO; n = 6/group) revealed no significant difference
in the analytes measured. Of note, many of the measured
cytokines from sham (n = 6) samples were below the level
of detection, in contrast to the CCI (n = 6) samples which
all yielded measurable amounts. Following CCI, both ipsi-
lateral and contralateral hemispheres from Cav-1 (n = 6)
and Cav-3 KO (n = 6) exhibited significant elevation in
IL-1β, IL-2, IL-6, IL-9, IL-10, IL-17, KC, MCP-1, MIP-1α,
and GMCSF compared to the respective transgenic sham
corresponding hemispheres (that is, ipsilateral and contra-
lateral) (P = 0.0005, two-way ANOVA, Table 1). For WT
alone, CCI significantly enhanced IL-1β, IL-9, IL-10, KC,
and MCP-1 in ipsilateral hemisphere and IL-9, IL-10, IL-
17, and MIP-1α in contralateral versus corresponding
sham hemisphere. For Cav-1 KO, CCI significantly ele-
vated IL-1β, IL-2, IL-6, IL-9, IL-10, IL-17, KC, and MCP-1
versus ipsilateral Cav-1 KO sham and significantly in-
creased all 10 cytokines/chemokines versus contralateral
Cav-1 KO sham. When compared to WT CCI corre-
sponding hemisphere, Cav-1 CCI increased IL-2, IL-6, KC
and MCP-1 in ipsilateral and IL-6, IL-9, IL-17 and KC in
contralateral. For Cav-3 KO, all 10 cytokines/chemokines
were significantly elevated in both ipsilateral and contra-
lateral versus Cav-3 KO corresponding sham hemispheres.
Figure 4 Caveolin (Cav)-1 knock-out (KO) and Cav-3 KO mice have different microglial and astrocyte populations. Primary mixed glia
were cultured from brains from wild-type (WT), Cav-1 KO and Cav-3 KO postnatal day 3 pups. (A)Western blot (WB) analysis of GFAP (glial fibrillary
acidic protein) and Iba1 (ionized calcium-binding adapter molecule 1) in primary mixed glia cultures normalized to GAPDH. (B) Immunofluorescence
microscopy of GFAP (green) and Iba1 (red) in primary mixed glia cultures. Nuclei were stained with DAPI. (C) Sections of hippocampal CA1 and dentate
gyrus (DG) regions from WT, Cav-1 KO and Cav-3 KO mice labeled with Iba1 (left) and GFAP (right). (D) Sections of hippocampal CA1 region with the
neuronal dendritic marker MAP2 (microtubule associated protein 2). (E) Quantitation of cell numbers from n = 3 animals. A statistically significant
increase in Iba1 cells is found in Cav-3 KO mice compared to WT (P < 0.01, left graph). A significant decrease in GFAP labeling is found in Cav-3 KO
mice compared to Cav-1 KO (P < 0.01, middle graph), and a trending decrease when compared to WT (not significant). A statistically significant increase
in MAP2 labeling is also detected in Cav-3 KO versus Cav-1 KO (P < 0.01, right graph). Data displayed as mean ± SEM. (F) Bottom panels are quantitative
WB analysis of Iba1, GFAP and β3-tubulin from mouse hippocampi. Statistically significant increased expression of Iba1 and β3-tubulin and decreased
GFAP expression was detected in Cav-3 KO mice. Conversely, decreased Iba1 expression was observed in Cav-1 KO.
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nificant increase in all 10 cytokines/chemokines in both
hemispheres except for IL-17 (ipsilateral) and MIP-1α
(contralateral). When compared to Cav-1 KO CCI, Cav-3KO CCI had a significant increase in IL-1β, IL-9, KC,
MCP-1, MIP-1α, and GMCSF in the ipsilateral hemi-
sphere and IL-1β, IL-2, IL-9, IL-10, and IL-17 in the
contralateral hemisphere.
Figure 5 Controlled cortical impact (CCI) causes a significant
larger brain lesion volume in caveolin (Cav)-1 and Cav-3
knock-out (KO) mice compared wild-type (WT). WT, Cav-1 and
Cav-3 KO mice were subjected to CCI and lesion volume was
quantitated on Masson’s trichrome stained histological sections
24 hours following impact as previously described [22]. Cav-1
(11.9 ± 1.2 mm3) and Cav-3 KO (15.1 ± 2.2 mm3) mice had a significant
larger brain lesion volume compared to WT (7.5 ± 0.8 mm3) and sham
(0.8 ± 0.4 mm3) (P < 0.0001, n = 4). Data displayed as mean ± SEM.
(A) Representative Masson’s trichrome stained coronal brain sections.
(B) Quantitation of lesion volume shown in (A).
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The current findings are the first to demonstrate that
loss of Cav isoforms produces isoform-specific effects on
inflammation in a CCI model of TBI. The objective of
the present study was to quantitatively assess neuroin-
flammation in the brain of Cav-1 KO and Cav-3 KO
mice early after CCI. Many previously published studies
have evaluated downstream signaling proteins involved
in the induction of cytokines/chemokines after injury
[35,36], but none have directly investigated the role of
Cav and MLR-localized receptors and associated down-
stream signaling mediators on TBI-induced inflamma-
tory responses. The loss of Cav-1, specifically, has been
found to result in increased ischemic damage following
transient middle cerebral artery occusion [37]. One pos-
sible mechanism for increased injury is a lack of eNOS
inhibition by Cav-1 leading to increased metalloprotein-
ase activity and blood–brain barrier degradation [38].
Because both microglia and astrocytes express Cav-1and Cav-3, it is critical to understand how these proteins
regulate receptor signaling, and secondary messengers
such as NO, to induce or repress inflammation following
CNS injury. Moreover, Cav-1 KO mice have previously
been shown to exhibit enhanced anxiety and impaired
spatial memory, demonstrating an important role for
Cav-1 in normal neurological phenotype [39]. Although it
has yet to be determined which cell type contributes to
these behavioral abnormalities, our previous work that
demonstrates a reduction in MLR and MLR-localized syn-
aptic proteins accompanied with reduced hippocampal
synapses does indicate in part that loss of Cav-1 causes
cellular morphological changes essential for normal brain
physiology regardless of the cell type [19].
Using a well-characterized CCI model of TBI, we de-
tected glial reactivity in the ipsilateral hemisphere 4 hours
post-injury and hippocampal neuronal death 24 hours
post-injury. Behavioral studies revealed cognitive deficits
in working memory, as determined by T-maze, 3 months
post-injury with no motor deficits. Not surprisingly, the
damage was not limited to the hippocampus, as extensive
parietal cortical damage was also evident by 4 hours,
which included enhanced neuroinflammation as indicated
by the significantly elevated cytokine production in the ip-
silateral cortex.
TBI can produce epileptogenesis, a neuropathological
change that is frequently associated with depression,
anxiety disorders and side effects from anti-epileptic
treatments [40]. PTE is a significant complication for the
returning Veteran population with estimates that ap-
proximately 34% of returning Veterans who experienced
moderate to severe head trauma are at risk for develop-
ing PTE. The findings from the current study show an
increase in polysynaptic responses in the CCI hippocam-
pal hemisphere, an indicator of increased pro-epileptic
activity. Such a finding is a potential indicator of increased
pro-epileptic activity because aberrant circuit formation
is believed to be involved in epileptogenesis [41,42].
Therefore, these results (that is, enhanced polysynaptic re-
sponses) could be an important factor contributing to the
post-TBI death of hippocampal neurons and development
of epilepsy.
Another putative mechanism involved in the develop-
ment of PTE is enhanced generation of reactive oxygen
species [43], as seen in the current study (Figure 2D,E).
Previous studies have shown Nox activation leads to in-
creased neurotoxic activation of microglia [44]. Gene
array studies have shown that changes in synaptic plasti-
city, glial proliferation and inflammatory reactivity occur
before initial seizures manifest [45,46]. Anti-epileptic
drugs, as a prophylactic intervention administered soon
after TBI, have shown some efficacy in preventing early
seizures (< 1 week), but are ineffective in preventing later,
more devastating episodes of seizures [47]. Therefore,
Table 1 Multiplex array reveals brain changes in certain cytokines, chemokines, and growth factors after CCI
Ipsilateral Contralateral
WT Cav-I KO Cav-3 KO WT Cav-1 KO Cav-3 KO
Sham TBI Sham TBI Sham TBI Sham TBI Sham TBI Sham TBI
IL-1β 0.072 ± 0.004 0.83 ± 0.06* 0.06 ± 0.005 1.4 ± 0.3* 0.07 ± 0.007 2.5 ± 0.4*# 0.08 ± 0.01 0.59 ± 0.07 0.06 ± 0.005 1.05 ± 0.13* 0.07 ± 0.01 2.3 ± 0.2*#^
IL-2 011 ± 0.002 0.36 ± 0.03 0.11 ± 0.005 0.7 ± 0.07*# 013 ± 0.004 0.96 ± 0.15# 0.11 ± 0.01 0.22 ± 0.05 0.12 ± 0.004 0.6 ± 0.1* 0.13 ± 0.01 0.9 ± 0.1*#^
IL-6 0.04 ± 0.006 2.0 ± 0.4 0.03 ± 0.007 30.9 ± 3.9*# 0.03 ± 0.003 42.2 ± 7.1*# 0.03 ± 0.005 0.58 ± 0.06 0.02 ± 0.001 14.2 ± 3.9*#δ 0.02 ± 0.005 7.5 ± 1.3*#
IL-9 0.69 ± 0.03 9.6 ± 0.4* 0.6 ± 0.06 15.1 ± 1.5* 0.8 ± 0.09 23.3 ± 3.3*#^ 0.79 ± 0.19 7.4 ± 1.3* 0.8 ± 0.03 13.6 ± 2.2*# 0.7 ± 0.06 21.0 ± 1.5*#^
IL-10 0.034 ± 0.003 1.0 ± 0.08* 0.04 ± 0.003 1.5 ± 0.2* 0.06 ± 0.002 2.0 ± 0.3*# 0.046 ± 0.012 0.62 ± 0.08* 0.04 ± 0.001 1.03 ± 0.17* 0.05 ± 0.01 1.8 ± 0.1*#^
IL-I7 0.0009 ± 0.0003 0.22 ± 0.02 0.002 ± 0.0003 0.3 ± 0.04* 0.003 ± 0.0001 0.4 ± 0.1* 0.0014 ± 0.0005 0.13 ± 0.03* 0.001 ± 0.0002 0.3 ± 0.05*# 0.003 ± 0.001 0.4 ± 0.04*#^
KC 0054 ± 0.01 6.3 ± 1.2* 0.05 ± 0.006 31.8 ± 3.1*# 0.05 ± 0.005 49.1 ± 7.7*#^ 0.027 ± 0.009 1.6 ± 0.2 0.02 ± 0.001 9.5 ± 1.8*# 0.03 ± 0.01 11.0 ± 2.5*#
MCP-1 0.051 ± 0.004 7.0 ± 2.2* 0.05 ± 0.009 19.4 ± 1.5*# 0.05 ± 0.004 39.4 ± 6.3*#^ 0.042 ± 0.009 1.9 ± 0.2 0.04 ± 0.004 5.6 ± 1.2* 0.07 ± 0.01 8.6 ± 1.9*#
MIP-1α 0.031 ± 0.004 2.0 ± 0.07 0.02 ± 0.008 6.7 ± 0.6 0.03 ± 0.003 20.1 ± 4.8*#^ 0.022 ± 0.006 1.6 ± 0.2* 0.01 ± 0.002 2.0 ± 0.6* 0.02 ± 0.01 2.4 ± 0.3*
GMCSF NA 0.84 ± 0.2 NA 1.9 ± 0.6 0.2 ± 0.03 3.4 ± 0.6*#^ 0.14 ± 0.05 0.7 ± 0.2 0.11 ± 0.01 2.0 ± 0.4*# 0.3 ± 0.04 2.5 ± 0.3*#
Four hours post-CCI, contralateral and ipsilateral hemispheres were analyzed with the MAGPIX Cytokine Multiplex Assay for IL-1β, IL-2, IL-6, IL-9, IL-10, IL-17, KC (keratinocyte chemoattractant), monocyte chemoattractant
protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), and granulocyte-macrophage colony-stimulating factor (GMCSF). Data (n = 6 mice/group) represent mean ± SEM. P < 0.05 or less were considered
statistically significant. *P < 0.05 versus sham hemisphere, #P < 0.05 versus wild-type (WT) traumatic brain injury (TBI) hemisphere, ^P < 0.05 versus caveolin (Cav)-1 knock-out (KO) TBI hemisphere, δP < 0.05 versus Cav-3 KO TBI
hemisphere. NA, not available (below detection).
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key changes may alter the course of PTE development
and potentially reverse the long-term cognitive changes
that result from TBI.
We have previously shown a role for Cavs as regula-
tors of neuronal survival [19,24,25] and microglia activa-
tion [20]. In an attempt to understand the potential role
of Cavs in mediating the early inflammatory responses
after TBI, 23 cytokines were measured 4 hours post-
injury. Interestingly, 10 analytes were significantly ele-
vated in both hemispheres of brains from either Cav-1
KO or Cav-3 KO mice. Common pro-inflammatory cy-
tokines/chemokines, including IL-1β, IL-2, IL-6, IL-9,
IL-10, IL-17, KC, MCP-1, MIP-1α, and GMCSF were
upregulated in both Cav KO mice, yet only IL-6, KC,
MCP-1, and MIP-1α were significantly elevated with
CCI compared to the contralateral Cav. MCP-1 (CCL2)
was significantly increased in the contralateral and ipsi-
lateral hemisphere of both Cav KO mice; these results
are in agreement with previously published work that
demonstrated increased expression in a pilocarpine model
of status epilepticus [48]. Persistently elevated expression
of MCP-1 in both Cav KO mice indicates a disruption in
the normal signaling and trafficking of the MCP-1/CCR2
(MCP-1 receptor) complex, an interesting finding consid-
ering that previous work showed that MCP-1 KO mice
have attenuated lesion size and less astrogliosis following
TBI [49]. Other studies have shown that Cav-1 plays
a prominent role in astrocytic responses to MCP-1 by
mediation of cellular signaling transduction through
caveolae-localized CCR2 [50,51]. Therefore, interven-
tions that increase Cav expression and restore normal
CCR2 expression and function may be a potential
therapeutic target. As a final Cav-mediated chemokine
example from the multiplex analysis, MIP-1α (CCL3),
a ligand for CCR5 (MIP-1α receptor), is significantly
elevated after CCI in the ipsilateral hemisphere. Al-
though many groups have found increased expression
of MIP-1α following induced status epilepticus models,
the role for MIP-1α, either protective or inflammatory, is
still under debate [52].
Various G-protein coupled receptors that are regulated
by Cav, such as adenosine receptors, are involved in the
complex process of microglia or astrocyte activation
[53-56]. The data from the current study demonstrated
reduced expression of adenosine A1AR and the anti-
inflammatory A3AR in both Cav-1 KO and Cav-3 KO
brains. Evidence exists that the loss of A1AR (A1AR KO
mice) results in an increased risk for epileptogenesis
[57,58]. Because the current data show a reduction in
A1AR expression in Cav KO mice, loss of Cav iso-
forms due to injury (as shown in Figure 1D) may
render the brain more susceptible to physiological changes
(Figure 2C) and subsequent seizure development.A2AAR sits at the intersection of multiple control points
for the development of neuropathology and neuro-
psychiatric conditions (reviewed in [59,60]). Activation
of A2AAR can negatively affect the functionality of
A1AR [61], resulting in an enhanced inflammatory state.
Additional evidence suggests that A2AAR activation plays
a major regulatory role in microglia-dependent neurotro-
phin release and subsequent microglia proliferation
during neuroinflammation [62]. The present findings
demonstrate that both Cav KO mice have increased MLR
localization of the pro-inflammatory A2AAR compared to
WT (Figure 3B). After injury, local adenosine concentra-
tions greatly increase activating plasmalemmal localized
A2AAR receptors in microglia [7,63]. The present finding
that Cav KO mice exhibit increased MLR-localized
A2AAR basally may in part explain the elevated cytokine/
chemokine production in the brains of these mice both
with and without CCI.
Cholesterol is a key component of MLR and for main-
taining synaptic integrity. Because synaptic loss is one of
the dynamic changes associated with the latency period
for development of PTE [64-67], changes in cholesterol
homeostasis and MLR integrity may in part contribute
to the etiology of PTE. Lipoprotein receptors are key
players in cholesterol homeostasis [68], and two import-
ant lipoprotein receptors in the brain, LRP-1 and LDL-
R, are subcellularly localized to MLR [33,34]. Because
Cav KO mice have reduced expression of LRP-1 and to
a lesser extent LDL-R compared to WT (Figure 3C),
events that cause decreased Cav expression in the brain
(age or injury) may reduce cholesterol transport from glia
to neurons and therefore increase the risk for synaptic loss,
intercellular events we are presently investigating [19].
Conclusions
We have demonstrated for the first time that loss of Cav
isoforms results in enhanced cytokine/chemokine produc-
tion following TBI. The present study extends previously
published results showing the neuropathology of Cav-1
KO mice, and shows for the first time that loss of Cav-3
significantly enhances cytokine/chemokine production in
the setting of TBI. The extent of injury and inflammation
was considerably greater in the Cav-1 KO and Cav-3 KO
mice. Some degree of inflammation is clearly necessary for
neuroregeneration and brain repair after TBI. Modulation
of the inflammatory response, rather than its suppression,
may be necessary. To that end, our data are consistent
with the premise that modulation of Cav-1 and Cav-3
levels in a cell-type-specific manner (neurons, astrocytes
and microglia) might afford novel therapeutic options for
the treatment of TBI.
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